AG311


CAS No. : 1126602-42-3

1126602-42-3
Price and Availability of CAS No. : 1126602-42-3
Size Price Stock
100 mg Get quote
250 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-116107
M.Wt: 321.40
Formula: C17H15N5S
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 1126602-42-3 :

AG311 is an anticancer and antimetastatic agent. AG311 induces rapid necrosis in numerous cancer cell lines[1]. In Vitro:AG311 (0-30 μM; 48 h) shows cytotoxicity against cancer cells[1].
AG311 (10-40 μM; 0-150 min) selectively induces membrane permeabilization in breast cancer cells (compared to HUVECs)[1].
AG311 (25 μM; 20 min) induces necrosis and lacks molecular markers of apoptosis in MDA-MB-435 cells[1].
AG311 (15-25 μM) affects calcium homeostasis and induces plasma membrane depolarization in MDA-MB-435 cells[1].
AG311 (5-20 μM) induces rapid mitochondrial membrane changes and mitochondrial dysfunction in MDA-MB-435 cells[1].
AG311 (0-14 μM; 30 h) inhibits breast cancer cell migration[1]. In Vivo:AG311 (23 mM; intratumoral; once daily for 2 days) increases necrosis in mice[1].
AG311 (45 mg/kg; i.p.; twice weekly for 30 days) inhibits tumor growth and lung metastases in mice[1].

Your information is safe with us.